Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear decrease » linear increase (Expand Search)
clinical cases » clinical care (Expand Search)
Showing 2,161 - 2,180 results of 25,426 for search '(( significant decrease decrease ) OR ( significant ((clinical cases) OR (linear decrease)) ))', query time: 0.61s Refine Results
  1. 2161
    Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis.

    Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2162
    Localization and conditional deletion of C/EBP in SKH1 mouse epidermis.

    Localization and conditional deletion of C/EBP in SKH1 mouse epidermis. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2163
    Data Sheet 2_Case Report: Clinical metastasis characteristics of lung adenosquamous carcinoma with ROS1 rearrangement.zip

    Data Sheet 2_Case Report: Clinical metastasis characteristics of lung adenosquamous carcinoma with ROS1 rearrangement.zip by Xi Chen (35903)

    Published 2025
    Save to List
    Saved in:
  4. 2164
    Data Sheet 1_Case Report: Clinical metastasis characteristics of lung adenosquamous carcinoma with ROS1 rearrangement.pdf

    Data Sheet 1_Case Report: Clinical metastasis characteristics of lung adenosquamous carcinoma with ROS1 rearrangement.pdf by Xi Chen (35903)

    Published 2025
    Save to List
    Saved in:
  5. 2165
    Comparisons of parasitemia with clinical status, age, Duffy genotypes, PvDBP gene copy numbers of samples based on qPCR assays.

    Comparisons of parasitemia with clinical status, age, Duffy genotypes, PvDBP gene copy numbers of samples based on qPCR assays. by Yasin Nasir (20721743)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2166
    The Laboratory Animal Flow Diagram.

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2167
    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).

    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2168
    General procedure for the synthesis of B.

    General procedure for the synthesis of B. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2169
    The trends of gene expression in the metabolism of triglycerides in liver tissue.

    The trends of gene expression in the metabolism of triglycerides in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2170
    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.

    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2171
    The trends of cholesterol metabolism-related gene expression in liver tissue.

    The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2172
    <sup>1</sup>H NMR spectra for kylo-0603.

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2173
    Kylo-0603’s EC50 & tissue levels.

    Kylo-0603’s EC50 & tissue levels. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2174
    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.

    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2175
    The trends in the expression of inflammation-related genes in liver tissue.

    The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2176
    The Fibrosis scoring by Sirius Red staining and SHG/TPEF.

    The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2177
    Effects of Kylo-0603 on body weight, organ weight, and body fat content.

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2178
    The trends in the expression of fibrosis-related genes in liver tissue.

    The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2179
    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.

    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2180
    Plasma cholesterol and LDL-C levels.

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: